论文部分内容阅读
目的：比较不同剂量氨溴索口服液治疗糖尿病合并社区获得性肺炎临床疗效。方法选取100例糖尿病合并社区获得性肺炎患者分为观察组与对照组，观察组患者给予两倍于对照组剂量氨溴索口服液口服治疗，1d3次。治疗7d后比较两组患者治疗效果与不良反应发生情况。结果观察组患者的治疗总有效率高于对照组，差异具统计学意义（p＜0.05）。两组患者均未发现不良反应。结论应用双倍剂量氨溴索口服液治疗糖尿病合并社区获得性肺炎患者疗效果更好。“,”Objective: To compare the different dose of ambroxol hydrochloride oral solution in the treatment of diabetic patients with community acquired pneumonia. Methods: 100 cases of diabetic patients with community acquired pneumonia were randomly divided into observation group and control group, the observation group were treated two times than that of the control group dose of ambroxol hydrochloride oral liquid oral therapy, 1d3. The occurrence and adverse reaction of patients with treatment effects were compared between the two groups after the treatment of 7d. Results: the patients in the treatment group the total efficiency is higher than that of the control group, the difference has statistical significance (P < 0.05). Adverse reactions were not found in the two groups of patients. Conclusion: the application of a double dose of ambroxol hydrochloride oral solution in the treatment of diabetic patients with community acquired pneumonia patients better treatment effect.